Proteins: Clinical Trials

2 trials of Proteins, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 11Completed 1

Follow Proteins: new trials by email Literature Review of Proteins trials Research Report on Proteins

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Metabolic Resuscitation for Septic Shock
Best Practice, early metabolic resuscitation - Multiple Organ Failure, Septic Shock
Phase 2TerminatedM.D. Anderson Cancer Center22019-10-042024-10-29
Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults
DNA-HIV-PT123 vaccine, Bivalent Subtype C gp120/MF59 vaccine, Bivalent Subtype C gp120/AS01B vaccine - HIV Infections
Phase 1 / Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)3342016-12-072022-04-29

Conditions studied

HIV Infections (1)  ·  Multiple Organ Failure (1)  ·  Sepsis (1)  ·  Shock, Septic (1)

Sponsors

M.D. Anderson Cancer Center (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United States (2)  ·  South Africa (1)

Top investigators

Joseph L. Nates, MBA,MD (1)  ·  Nigel Garrett (1)

Results publications

PMID 30282622, PMID 34895272, PMID 38916429, PMID 40190112, PMID 40704585

NIH funding

P30CA016672 (1)